PortfoliosLab logoPortfoliosLab logo
ABBV vs. EPD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ABBV vs. EPD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AbbVie Inc. (ABBV) and Enterprise Products Partners L.P. (EPD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ABBV achieves a 1.30% return, which is significantly lower than EPD's 19.79% return. Over the past 10 years, ABBV has outperformed EPD with an annualized return of 19.10%, while EPD has yielded a comparatively lower 10.61% annualized return.


ABBV

1D
1.32%
1M
9.22%
YTD
1.30%
6M
3.65%
1Y
22.21%
3Y*
22.39%
5Y*
18.94%
10Y*
19.10%

EPD

1D
-0.08%
1M
-2.72%
YTD
19.79%
6M
19.53%
1Y
24.43%
3Y*
20.73%
5Y*
15.96%
10Y*
10.61%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ABBV vs. EPD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ABBV
AbbVie Inc.
1.30%33.08%18.86%-0.23%24.01%32.43%27.72%1.47%-0.96%60.07%
EPD
Enterprise Products Partners L.P.
19.79%9.45%28.00%17.71%18.32%21.40%-23.61%21.88%-1.32%4.24%

Correlation

The correlation between ABBV and EPD is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.21

Correlation (5Y)
Calculated over the trailing 5-year period

0.18

Correlation (10Y)
Calculated over the trailing 10-year period

0.22

Correlation (All Time)
Calculated using the full available price history since Jan 2, 2013

0.24

Fundamentals

Market Cap

ABBV:

$403.99B

EPD:

$81.47B

EPS

ABBV:

$2.05

EPD:

$2.69

PE Ratio

ABBV:

110.96

EPD:

13.83

PS Ratio

ABBV:

6.43

EPD:

1.58

Total Revenue (TTM)

ABBV:

$62.82B

EPD:

$51.57B

Gross Profit (TTM)

ABBV:

$46.15B

EPD:

$7.31B

EBITDA (TTM)

ABBV:

$17.96B

EPD:

$10.11B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ABBV vs. EPD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ABBV
ABBV Risk / Return Rank: 6868
Overall Rank
ABBV Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
ABBV Sortino Ratio Rank: 6666
Sortino Ratio Rank
ABBV Omega Ratio Rank: 6565
Omega Ratio Rank
ABBV Calmar Ratio Rank: 6868
Calmar Ratio Rank
ABBV Martin Ratio Rank: 6868
Martin Ratio Rank

EPD
EPD Risk / Return Rank: 8383
Overall Rank
EPD Sharpe Ratio Rank: 8484
Sharpe Ratio Rank
EPD Sortino Ratio Rank: 8181
Sortino Ratio Rank
EPD Omega Ratio Rank: 7979
Omega Ratio Rank
EPD Calmar Ratio Rank: 8585
Calmar Ratio Rank
EPD Martin Ratio Rank: 8888
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ABBV vs. EPD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and Enterprise Products Partners L.P. (EPD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ABBVEPDDifference
Sharpe ratioReturn per unit of total volatility

-0.63

Sortino ratioReturn per unit of downside risk

-0.83

Omega ratioGain probability vs. loss probability

1.18

1.28

-0.10

Calmar ratioReturn relative to maximum drawdown

1.29

3.24

-1.96

Martin ratioReturn relative to average drawdown

2.88

9.50

-6.62

ABBV vs. EPD - Sharpe Ratio Comparison

The current ABBV Sharpe Ratio is 0.92, which is lower than the EPD Sharpe Ratio of 1.54. The chart below compares the historical Sharpe Ratios of ABBV and EPD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ABBV vs. EPD - Drawdown Comparison

The maximum ABBV drawdown since its inception was -45.09%, smaller than the maximum EPD drawdown of -58.78%. Use the drawdown chart below to compare losses from any high point for ABBV and EPD.


Loading charts...

Drawdown Indicators


ABBVEPDDifference

Max Drawdown

Largest peak-to-trough decline

-45.09%

-58.78%

+13.69%

Max Drawdown (1Y)

Largest decline over 1 year

-17.32%

-7.56%

-9.76%

Max Drawdown (3Y)

Largest decline over 3 years

-20.74%

-15.40%

-5.34%

Max Drawdown (5Y)

Largest decline over 5 years

-21.92%

-18.06%

-3.86%

Max Drawdown (10Y)

Largest decline over 10 years

-45.09%

-58.04%

+12.95%

Current Drawdown

Current decline from peak

-4.60%

-6.41%

+1.81%

Average Drawdown

Average peak-to-trough decline

-10.71%

-10.22%

-0.49%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.75%

2.58%

+5.17%

Volatility

ABBV vs. EPD - Volatility Comparison

AbbVie Inc. (ABBV) and Enterprise Products Partners L.P. (EPD) have volatilities of 6.10% and 6.00%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ABBVEPDDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.10%

6.00%

+0.10%

Volatility (6M)

Calculated over the trailing 6-month period

17.85%

13.27%

+4.58%

Volatility (1Y)

Calculated over the trailing 1-year period

24.31%

15.90%

+8.41%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

22.89%

17.23%

+5.66%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.73%

24.14%

+1.59%

Dividends

ABBV vs. EPD - Dividend Comparison

ABBV's dividend yield for the trailing twelve months is around 2.96%, less than EPD's 5.88% yield.


PositionTTM20252024202320222021202020192018201720162015
ABBV
AbbVie Inc.
2.96%2.87%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%
EPD
Enterprise Products Partners L.P.
5.88%6.74%6.63%7.51%7.79%8.20%9.09%6.23%6.97%6.29%5.88%5.90%

Financials

ABBV vs. EPD - Financials Comparison

This section allows you to compare key financial metrics between AbbVie Inc. and Enterprise Products Partners L.P.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


10.00B12.00B14.00B16.00B20222023202420252026
15.00B
14.39B
(ABBV) Total Revenue
(EPD) Total Revenue
Values in USD except per share items

ABBV vs. EPD - Profitability Comparison

The chart below illustrates the profitability comparison between AbbVie Inc. and Enterprise Products Partners L.P. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%20222023202420252026
83.5%
13.1%
Portfolio components
ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.

EPD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Enterprise Products Partners L.P. reported a gross profit of 1.88B and revenue of 14.39B. Therefore, the gross margin over that period was 13.1%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.

EPD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Enterprise Products Partners L.P. reported an operating income of 1.82B and revenue of 14.39B, resulting in an operating margin of 12.6%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.

EPD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Enterprise Products Partners L.P. reported a net income of 1.48B and revenue of 14.39B, resulting in a net margin of 10.3%.


Frequently Asked Questions


ABBV and EPD have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ABBV has higher volatility (6.10%) compared to EPD (6.00%). In terms of maximum drawdown, ABBV dropped -45.09% vs EPD's -58.78%.

EPD currently has the higher Sharpe Ratio (1.54 vs 0.92), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ABBV and EPD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer